Corporate legal teams can embrace the AI revolution by encouraging experimentation and managing risks proactively, according ...

BlueAllele “plausibly alleged” that some of Intellia’s uses of technology were not reasonably related to FDA approval | ...

As President-elect Donald Trump prepares for his second term, the life sciences industry is calling for predictability, finds ...

Jury finds medical device company misappropriated secrets covering Insulet’s Omnipod l Insulet “extremely pleased” with ...

German biotech asks federal judge to reject Amgen’s efforts to narrow scope of a key patent in ongoing dispute | Patent ...

One-day event in London brings in-house counsel and private practitioners together | First sessions to kick off the day ...

Former EIP partner joins IP and technology practice | New London hire is known for high-stakes, cross-border patent litigation. Already registered?